BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 5, 2020
View Archived Issues
Picturing molecular alterations
Read More
AC Immune to advance anti-TDP-43 antibody toward clinical development
Read More
IL12-L19L19 trial underway in advanced solid carcinomas and DLBCL
Read More
Phase II trial of EPX-100 underway in children with Dravet syndrome
Read More
Novel humanized platelet mouse model predicts efficacy of experimental antiplatelet drugs
Read More
Chinese investigators patent IDO1 inhibitors
Read More
Minghui Pharmaceutical presents new BTK inhibitors
Read More
Biogen synthesizes new IRAK-4 inhibitors
Read More
Dogma Therapeutics describes PCSK9 inhibitors
Read More
BiSiChem identifies new ALK inhibitors
Read More
Regenxbio reports positive interim phase I/IIa data and program updates for RGX-314
Read More
In vitro data show VERU-111 suppresses key cytokines responsible for severe ARDS in COVID-19
Read More
Independent IRB grants approval for phase II study of LSALT peptide in severe COVID-19
Read More
Catabasis and Gates MRI to study CAT-5571 in drug-sensitive and drug-resistant tuberculosis
Read More
Gallium-68-labeled denosumab synthesized for PET imaging of tumor microenvironment
Read More
Probiotics affect brain peptidome via gut-brain axis
Read More
SEMA3C identified as promising therapeutic target in bladder cancer
Read More
AC Immune describes enhanced alpha-synuclein PET tracers
Read More
First-in-human study of [124I]JS-001 PET/CT and PET/MR in patients with melanoma
Read More
European Commission grants conditional marketing authorization for Hepcludex
Read More
Phase I/II trial set to evaluate ARO-ENaC in cystic fibrosis
Read More
FDA clears IND application to initiate clinical trial of niclosamide in patients with COVID-19
Read More
Topline data from phase II/III registration study of pegloprastide
Read More
Positive phase I data for COVID-19 vaccine candidate NVX-CoV2373
Read More
Aerpio announces funding from MTEC to evaluate razuprotafib in patients with COVID-19
Read More
Nabota demonstrates palliative effect on bruxism
Read More